HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allan Lipton Selected Research

Prostatic Neoplasms (Prostate Cancer)

7/2020Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases.
9/2015Hypocalcaemia in patients with metastatic bone disease treated with denosumab.
4/2015Antiresorptive therapy in the management of cancer treatment-induced bone loss.
1/2013RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.
7/2012Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.
1/2012Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
1/2012Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.
2/2011Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
1/2011Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.
1/2011Zoledronic acid use in cancer patients: more than just supportive care?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allan Lipton Research Topics

Disease

79Neoplasm Metastasis (Metastasis)
04/2022 - 01/2002
76Neoplasms (Cancer)
04/2022 - 07/2002
74Breast Neoplasms (Breast Cancer)
11/2020 - 01/2002
29Prostatic Neoplasms (Prostate Cancer)
07/2020 - 01/2002
25Bone Diseases (Bone Disease)
09/2015 - 09/2002
20Bone Resorption
01/2012 - 02/2003
18Multiple Myeloma
04/2022 - 09/2002
15Pain (Aches)
04/2022 - 04/2003
10Disease Progression
12/2016 - 02/2002
10Spontaneous Fractures (Pathological Fracture)
10/2010 - 09/2003
7Lung Neoplasms (Lung Cancer)
06/2013 - 04/2006
7Spinal Cord Compression
10/2010 - 09/2003
5Osteoporosis
07/2017 - 10/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011 - 01/2004
4Osteonecrosis (Kienbock's Disease)
04/2022 - 05/2007
4Metabolic Bone Diseases (Osteopenia)
07/2017 - 06/2005
4Renal Cell Carcinoma (Grawitz Tumor)
11/2005 - 02/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2019 - 12/2004
3Fatigue
12/2011 - 02/2003
3Hypercalcemia (Milk Alkali Syndrome)
03/2010 - 04/2006
2Hypocalcemia
04/2022 - 12/2010
2Carcinogenesis
12/2019 - 02/2011
2Nausea
12/2011 - 09/2003
2Diarrhea
12/2011 - 11/2009
2Urogenital Neoplasms
06/2006 - 11/2005
2Osteolysis
01/2005 - 05/2004
2Carcinoma (Carcinomatosis)
08/2003 - 02/2003
1Femoral Fractures (Femoral Fracture)
04/2022
1Fibrosis (Cirrhosis)
03/2022

Drug/Important Bio-Agent (IBA)

59Zoledronic Acid (Zometa)FDA Link
04/2022 - 01/2002
50Diphosphonates (Bisphosphonates)IBA
04/2022 - 01/2002
18DenosumabFDA Link
04/2022 - 02/2006
16Biomarkers (Surrogate Marker)IBA
11/2020 - 02/2002
15Hormones (Hormone)IBA
07/2017 - 01/2002
15Pamidronate (Aredia)FDA LinkGeneric
07/2017 - 02/2003
13Collagen Type I (Type I Collagen)IBA
08/2017 - 02/2002
13collagen type I trimeric cross-linked peptideIBA
12/2016 - 02/2002
10Trastuzumab (Herceptin)FDA Link
11/2020 - 09/2008
9Proteins (Proteins, Gene)FDA Link
12/2018 - 11/2002
9Monoclonal AntibodiesIBA
07/2012 - 10/2007
8Aromatase InhibitorsIBA
07/2017 - 03/2002
6Estrogen ReceptorsIBA
12/2016 - 03/2002
6TamoxifenFDA LinkGeneric
09/2011 - 11/2002
6RANK LigandIBA
09/2011 - 06/2005
5Lapatinib (GW572016)FDA Link
11/2020 - 02/2007
5CollagenIBA
12/2019 - 02/2003
5Tissue Inhibitor of Metalloproteinase-1IBA
08/2017 - 05/2007
5Alkaline PhosphataseIBA
09/2015 - 01/2005
5CreatinineIBA
09/2015 - 02/2003
5AndrogensIBA
04/2015 - 01/2004
5Clodronic Acid (Clodronate)IBA
08/2010 - 01/2004
5Analgesics (Analgesic Drugs)IBA
08/2007 - 04/2003
4LigandsIBA
04/2022 - 09/2008
4Peptides (Polypeptides)IBA
03/2022 - 02/2002
4Bone Density Conservation AgentsIBA
12/2016 - 08/2010
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2013 - 08/2007
4Phosphotransferases (Kinase)IBA
08/2010 - 03/2004
3Matrix Metalloproteinases (MMPs)IBA
08/2017 - 02/2011
3CalciumIBA
09/2015 - 02/2003
3Paclitaxel (Taxol)FDA LinkGeneric
12/2011 - 02/2003
3Progesterone Receptors (Progesterone Receptor)IBA
12/2011 - 03/2002
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2010 - 08/2003
3Letrozole (Femara)FDA LinkGeneric
06/2008 - 03/2002
3ErbB Receptors (EGF Receptor)IBA
02/2008 - 02/2003
3OsteoprotegerinIBA
06/2005 - 07/2002
2Opioid Analgesics (Opioids)IBA
04/2022 - 02/2013
2Cathepsin KIBA
11/2018 - 06/2005
2taxaneIBA
08/2017 - 02/2003
2Formaldehyde (Formol)FDA Link
08/2013 - 08/2010
2ParaffinIBA
08/2013 - 08/2010
2AlbuminsIBA
06/2013 - 02/2003
2Estrogens (Estrogen)FDA Link
01/2012 - 11/2002
2Carboplatin (JM8)FDA LinkGeneric
12/2011 - 11/2009
2human ERBB2 proteinIBA
11/2011 - 11/2010
2Antineoplastic Agents (Antineoplastics)IBA
03/2011 - 10/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2011 - 05/2004
2ImmunosorbentsIBA
02/2011 - 06/2004
2EnzymesIBA
02/2011 - 06/2004
2Edetic Acid (EDTA)FDA Link
02/2011 - 02/2003
2Celecoxib (Celebrex)FDA Link
04/2010 - 12/2004
2Irinotecan (Camptosar)FDA LinkGeneric
04/2010 - 12/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2010 - 12/2004
2GemcitabineFDA Link
04/2010 - 12/2004
2AntibodiesIBA
09/2008 - 06/2005
2Ibandronic Acid (Boniva)FDA Link
01/2007 - 04/2006
2RNA (Ribonucleic Acid)IBA
12/2004 - 02/2003
2Oncogene Proteins (Oncogene Protein)IBA
06/2004 - 10/2003
2Docetaxel (Taxotere)FDA Link
08/2003 - 02/2003
2Taxoids (Taxanes)IBA
08/2003 - 02/2003
2Megestrol Acetate (Borea)FDA LinkGeneric
08/2002 - 03/2002
2FadrozoleIBA
08/2002 - 03/2002
1Collagen Type III (Type III Collagen)IBA
03/2022

Therapy/Procedure

64Therapeutics
01/2021 - 01/2002
11Radiotherapy
10/2010 - 02/2003
7Drug Therapy (Chemotherapy)
04/2015 - 01/2002
4Castration
07/2020 - 06/2006
3Orthopedic Procedures
01/2007 - 03/2005
3Intravenous Infusions
06/2005 - 04/2003
2Dental Care
07/2007 - 05/2007
2Duration of Therapy
01/2007 - 09/2002